CNR Institutional Research Information System

PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.838
NA - Nord America 1.290
SA - Sud America 355
EU - Europa 332
AF - Africa 25
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.249
SG - Singapore 845
CN - Cina 347
BR - Brasile 279
HK - Hong Kong 188
VN - Vietnam 145
FR - Francia 111
IT - Italia 98
BD - Bangladesh 92
KR - Corea 68
JP - Giappone 53
IN - India 31
AR - Argentina 28
CA - Canada 26
DE - Germania 19
GB - Regno Unito 16
TR - Turchia 13
EC - Ecuador 11
ID - Indonesia 11
IL - Israele 11
RU - Federazione Russa 11
FI - Finlandia 10
NL - Olanda 10
UA - Ucraina 10
CL - Cile 8
CO - Colombia 8
VE - Venezuela 8
PK - Pakistan 7
CH - Svizzera 6
ES - Italia 6
IQ - Iraq 6
AT - Austria 5
EG - Egitto 5
MX - Messico 5
PL - Polonia 5
ZA - Sudafrica 5
SA - Arabia Saudita 4
UY - Uruguay 4
DK - Danimarca 3
DZ - Algeria 3
IE - Irlanda 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BB - Barbados 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GE - Georgia 2
JO - Giordania 2
MA - Marocco 2
MT - Malta 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.843
Salva come PNG Salva come JPEG
Città #
Santa Clara 741
Singapore 483
Hong Kong 188
Hefei 153
Lauterbourg 93
San Jose 85
Beijing 75
Seoul 68
Ashburn 58
Tokyo 43
Ho Chi Minh City 41
Hanoi 38
Los Angeles 38
New York 32
São Paulo 21
Buffalo 12
Dallas 12
Haiphong 10
Helsinki 10
Minamishinagawa 10
Naples 10
Rome 10
Da Nang 9
Toronto 9
Amsterdam 8
Bengaluru 8
Montreal 8
Orem 8
Frankfurt am Main 7
Istanbul 7
Rio de Janeiro 7
Chicago 6
Guangzhou 6
Kyiv 6
Milan 6
Quito 6
Chennai 5
Curitiba 5
Dhaka 5
Guayaquil 5
Hải Dương 5
Seattle 5
São Bernardo do Campo 5
Bellinzona 4
Belo Horizonte 4
Bogotá 4
Buenos Aires 4
Cairo 4
Charlotte 4
Cleveland 4
Goiânia 4
Guarulhos 4
Montevideo 4
Mumbai 4
Ninh Bình 4
Phoenix 4
Porto Alegre 4
Praia Grande 4
Santiago 4
Thái Nguyên 4
Turin 4
Warsaw 4
Americana 3
Brooklyn 3
Cagliari 3
Campinas 3
Catania 3
Caxias do Sul 3
City of London 3
Denver 3
Ha Long 3
Houston 3
Manaus 3
Manchester 3
Maringá 3
Marseille 3
Nairobi 3
Nha Trang 3
Nuremberg 3
Quận Phú Nhuận 3
Sorocaba 3
São Luís 3
Thái Bình 3
Vitória da Conquista 3
Abu Dhabi 2
Algiers 2
Atlanta 2
Bari 2
Bauru 2
Betim 2
Biên Hòa 2
Bologna 2
Bragança Paulista 2
Bridgetown 2
Brussels 2
Bình Dương 2
Bắc Giang 2
Capão da Canoa 2
Caracas 2
Chengdu 2
Totale 2.541
Salva come PNG Salva come JPEG
Nome #
[(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. 75
PET/TC with [F-18]FDG to evaluate the response to helical tomotherapy in non small cell lung cancer and lung/mediastinal metastases 73
Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy. 67
Physical Performance of the new hybrid PET/CT Discovery-690. 65
Molecular imaging for prostate cancer diagnosing and for guiding tailored therapies 64
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 62
Performance of beta- and high-energy gamma probes for the detection of cancer tissue in experimental surgical resection beds. 60
Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD. 59
Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer 59
PET-CT FDG quantification of oncological lesions: a PVE correction method from measured L/B and lesion volume 58
Preoperative staging of cervical cancer: Is FDG PET/CT really effective in patients with Ib1 stage 55
Role of (18)F-FDG PET in the management of gestational trophoblastic neoplasia 55
Role of FDG-PET in the management of gestational trophoblastic neoplasia (GTN) 55
The role of Choline Positron Emission Tomography/Computed Tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer 52
Use of [11C]Choline-PET for the detection if meningioma: Comparison with [18F]FDG-PET 51
Effect of count rate on clinical performance of a large NaI crystal PET scanner: comparison with a multi-ring PET 50
Feasibility and preliminary results of (11)C Choline-PETt/CT guided Tomotherapy for lymph nodes relapses in prostate cancer patients 49
[(11)C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy. 48
Detection of Lymph-Node Metastases with Integrated [(11)C]Choline PET/CT in Patients with PSA Failure after Radical Retropubic Prostatectomy: Results Confirmed by Open Pelvic-Retroperitoneal Lymphadenectomy 46
Sarcoidosis mimicking metastatic gynaecological malignancies: A diagnostic and therapeutic challenge? 46
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 45
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. 44
Prognostic value of pre-therapy 18F-FDG PET/CT for the outcome of radiotherapy treatment in patients with head and neck cancer 44
18FDG PET/CT Image-Guided Simultaneous Integrated Boost Intensity-Modulated Radiotherapy in Head and Neck cancer 43
11C-Choline PET/CT image-guided radiotherapic treatment of lymph nodal recurrence in prostate cancer patients 43
Helical tomotherapy treatment planning of lymph-node relapses in prostate cancer: Clinical value of 11C-Choline PET/CT 43
Prognostic value of quantitative 18F-FDG PET biomarkers in breast cancer 43
Tumour hypoxia imaging with [(18)F]FAZA PET in head and neck cancer patients: a pilot study 42
11C-Choline PET/CT and PSA kinetics 42
Added value of PET/CT in the evaluation of Burkitt Lymphoma in adults 42
C-11 Choline versus F-18 Fluorodeoxyglucose for imaging meningiomas: an initial experience 42
Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis. 42
(11)C]Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen. 41
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by (18)F-FDG PET/CT 41
Assessment of inter-operator and inter-software variability (PMOD and CARIMAS) in MBF quantification with 13NH3 and 3D-PET 41
Writing PET into existence 40
Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer. 40
Impact of time-of-flight (TOF) and point-spread-function (PSF) PET on whole-body oncologic studies 40
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 39
11C-Choline PET/CT image-Guided Tomotherapy treatment of lymph node relapses in prostate cancer patients 38
Accuracy of [11C]CHOLINE PET/CT in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathological-validated series 38
(11)C choline-PET/CT guided tomotherapy for lymph nodes relapses in prostate cancer patients: feasibility and preliminary results 38
The clinical value of 18F-FDG PET/CT in the management of patients with suspected infection and fever of unknown origin 38
18F-FDG PET as a tool for imaging proliferation in breast cancer: correlation between partial volume-corrected SUV and MIB-1 proliferation index 37
[11C]Choline PET/CT for early detection of Prostate Cancer Recurrence in Patients in the Rising PSA Status 37
Imaging of proliferation in breast cancer with 18F-FDG PET: Correlation between partial volume corrected SUV and MiB-1 proliferation index 35
Value of [11C]choline-PET in RE.staging prostate cancer: a comparison with [18F]FDG 35
Incidental detection by [(11)C]choline PET/CT of meningiomas in prostate cancer patients 35
[C-11]Choline PET for preoperative staging of prostate cancer patiens and to monitor the hormonal therapy response: a PET/TC study 34
[(11)C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging. 34
Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study 33
Value of [18F]FDG-PET/CT in lymph-nodal staging of uterine cervical cancer patients 33
[11C]Choline PET/CT vs bone scintigraphy in the detection of bone metastases of prostate cancer patients with biochemical failure after primary treatment 33
Reply to the letter "Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients" 32
Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features 32
Increased [11C]Choline uptake in bronchioloalveolar cell carcinoma with negative [18F]FDG uptake. A PET/CT and pathology study 32
Role of 4D-PET/CT for target volume definition in the radiotherapy of lung cancer 32
Value of [11C]Choline-PET and contrast enhanced CT for staging of bladder cancer: Correlation with histopathological findings 32
Incidental Finding of Parathyroid Adenoma With 11C-Choline PET/CT 31
Value of [18F]FDG-PET in persistent ovarian carcinoma: A comparison with surgical and histopatological findings 31
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-years results 31
Endometrial Cancer: pre-operative lymph nodal staging with FDG PET/CT 31
[18F]FDG uptake in different types of NSCLC: Comparison with histological and molecular data. 30
Lymph nodal metastases: diagnosis and treatment 30
Value of (18F)FDG-PET in planning conformal radiotheraphy treatment in patients with lung cancer. 29
The role of PET/computed tomography scan in the management of prostate cancer 29
Patient with locally advanced pancreatic cancer referred to concomitant HTT and ChT: role of FDG PET/CT in staging and treatment monitoring 29
Changes in glucose metabolism in non-small cell lung cancer during and after radiotherapy: a PET/CT study 29
Thre sholding Segmentation of FDG PET Lung Lesions for RT Planning Purposes 29
Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse 29
Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using Tirapazamine 29
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 28
PET-CT for treatment planning in prostate cancer. 28
Motion management in positron emission tomography/computed tomography for radiation treatment planning 28
Evaluation of the clinical performances of a large Nal(TI) crystal 3D PET scanner 27
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 27
Initial experience with 18F-FDG PET/CT in malignant ovarian germ cell tumors 27
CT-PET versus PET in RE-staging patients with treated tumor and ingreasing markers. 26
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis 26
[11C]Choline: whole body biodistribution in the human, preliminary study with positron emission tomography. 26
Clinical and diagnostic assessment for therapeutic decisions in prostate cancer 26
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. 26
[18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. 26
[11C]Choline-PET sensitivity in re-staging prostate cancer patients: relationship with PSA serum level and influence of androgen ablation therapy 25
Positron detection for the intraoperative localisation of cancer deposits 25
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. 25
Advance ovarian carcinoma: Usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment 25
Role of FDG PET/CT in the preoperative staging of high-risk clinical early stage endometrial cancer 25
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 25
Correlation between [11C]Choline-PET sensitivity and PSA serum value in re-staging prostate cancer patients 24
PET/CT: single re-staging procedure for clinical management of patinets with suspected ovarian cancer recurrence 24
Is [11C]choline PET/CT recommended for restaging prostate cancer patients after radical prostatectomy when PSA is lower than 1 ng/ml? 24
PET/CT for radiotherapy: image acquisition and data processing. 24
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on (18)F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma. 24
Prognostic value of 18FDG PET-CT in patients with head and neck cancer candidates to radical radiotherapy 24
A thresholding segmentation method for PET FDG lung neoplastic lesions 23
Critical assessment of the performance of PSA kinetics for the prediction of [11C]Choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 22
Value of [11C]choline PET in re-staging prostate cancer: A comparison with [18F]FDG-PET. 22
Techniques for detection recurrent prostate cancer after radical prostaectomy 22
Value of PET/CT in clinical management of patients with suspected ovarian cancer recurrence 21
Totale 3.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.243
article - articoli 9.417
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 1 2 4 2
2024/20251.687 4 7 111 56 636 108 9 59 10 7 349 331
2025/20262.147 92 164 172 316 367 51 302 102 127 140 185 129
Totale 3.843